Skip to main content
. 2020 Sep 7;17(18):6511. doi: 10.3390/ijerph17186511

Table 8.

Main characteristics of Exercise Prescription.

Trial Duration (Wk.) Exercise Intensity Increment Sets Repetitions Sessions/Wk. Session Duration/Min
12 [7,8,26,27,28,29,31,38,41,45,55,56] NR [10,23,24,35,36,37] NR [7,8,24,26,27,28,29,41] NR [25] 8–10 [10,23,35,36] 1 [39] NR [9,20,21,23,38,39,40,45]
17 [9,20,21] <50% 1RM [32,33,34]
UB: 1-pound weights [46,47,48,49,50,51,52,53,54]
0.5 kg. [25]
10% → >12 reps/set [9,20,21,40]
5%–10% → 2 Sess. [56]
1 [10,31,35,36,38,56] 8–12 [7,8,9,20,21,26,27,28,29,37,39,40,41] 2 [8,10,26,27,28,29,31,32,33,34,35,36,37,40,45,46,47,48,49,50,51,52,53,54,55,56] 20–30 [24]
20–30 [10,23,25,32,33,34,35,36,39,40] 50%–80% 1RM [7,8,9,20,21,26,27,28,29,31,39,40,41,45,56] Modifying starting grip position [23]
Decreasing 5RM x module [32,33,34]
2 [9,10,20,21,23,24,35,36,37,39,40,46,47,48,49,50,51,52,53,54,55,56] 10–12 [10,35,36,38,45,46,47,48,49,50,51,52,53,54,55] 3 [7,9,20,21,38,41] >30–45 [37]
48 [10,24,35,36,46,47,48,49,50,51,52,53,54] >85% 1RM [10,35,36,46,47,48,49,50,51,52,53,54,55] Tolerance [10,25,35,36,37,39]
RPE = ≤3 [31,38]
3 [7,8,10,24,26,27,28,29,32,33,34,35,36,41,45,46,47,48,49,50,51,52,53,54,55,56] 11–18/20 [24,25,31,32,33,34] 4 [23,24] 50–60 [8,10,26,27,28,29,35,36]
96 [37] RPE of 3–5 [38] UB = 1/2 pound → 2 Sess. [46,47,48,49,50,51,52,53,54,55] 4 [56] 20–15 RM
10-6 RM [56]
>60–90 [46,47,48,49,50,51,52,53,54]
- - LB = Smallest possible increment [46,47,48,49,50,51,52,53,54,55]
1.81 kg→ >10 reps/third set [45]
- - - -

PP = Part of the program; NR = not reported; BW = body weight; 1RM = one-repetition maximum; UB = upper body strength; LB = lower body strength; RPE = rating of perceived exertion; Reps = repetitions; Sess. = sessions; Wk. = week; HL = high load; LL = low load.